-
"Development and advanced characterization of materials for integration at the tunnel-recombination junction of two-terminal silicon heterojunction / perovskite tandem solar cells"
-
Alpioner Therapeutics, a start-up originating from TIMC,* is developing a vaccine against Pseudomonas aeruginosa, a bacterium that is multi-resistant to antibiotics and causes serious harm to vulnerable people. Clinical trials on humans are set to begin in 2025.
-
Look no further than the U!Train Blended Intensive Programme. It's an exciting Unite! course, scheduled to depart, September 1st 2024.
-
"Characterization, modelling, and optimization of nanostructured oxygen electrodes for Solid Oxide Cell "
-
-
-
Semi-empirical and ab-initio simulation of quantum transport in nanoscale devices
-
Master Industrial Engineering Program Sustainable printed electronics
-
Networking Lunch at ENSE3 Bridges Students, InnoEnergy Alumni, and Industry Leaders
-
